Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the HEALing Communities Study-Reference-Cited by-同舟云学术

Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the HEALing Communities Study

Published:2023-12 Issue: Volume:122 Page:104241
ISSN:0955-3959
Container-title:International Journal of Drug Policy
language:en
Short-container-title:International Journal of Drug Policy

Author:

Davis Alissa,Stringer Kristi Lynn^ORCID,Drainoni Mari-Lynn,Oser Carrie B.,Knudsen Hannah K.^ORCID,Aldrich Alison,Surratt Hilary L.,Walker Daniel M.^ORCID,Gilbert Louisa,Downey Dget L.,Gardner Sam D.,Tan Sylvia,Lines Lisa M.^ORCID,Vandergrift Nathan^ORCID,Mack Nicole,Holloway JaNae^ORCID,Lunze Karsten,McAlearney Ann Scheck,Huerta Timothy R.,Goddard-Eckrich Dawn A.,El-Bassel Nabila

Funder

Substance Abuse and Mental Health Services Administration

National Institutes of Health

National Institute on Drug Abuse

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference108 articles.

1. Stigma by association: To what extent is the attitude toward naloxone affected by the stigma of opioid use disorder?;Adeosun;Journal of Pharmacy Practice,2022

2. On the definition of stigma;Andersen;Journal of Evaluation in Clinical Practice,2022

3. Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: A 5-year update: distribution of providers with a DEA waiver;Andrilla;The Journal of Rural Health,2019

4. Messaging to increase public support for naloxone distribution policies in the United States: Results from a randomized survey experiment;Bachhuber;PLoS One,2015

5. Measuring stigma in people with HIV: Psychometric assessment of the HIV stigma scale;Berger;Research in Nursing & Health,2001